New WHO model to help regulators in battle against counterfeits
This article was originally published in SRA
Executive Summary
The World Health Organization’s anticounterfeiting task force, IMPACT, has adopted a new model for risk communication strategies for drug regulatory authorities aimed at helping them raise awareness and share specific information on incidences of drug counterfeiting1.